文献速递重症综合管理与镇静镇痛

基于蛋白质组测序探索脓毒症患者肌肉减少症的可能原因

[Exploring the potential causes of sarcopenia in sepsis patients based on proteome sequencing].
PubMed 文献 · Zhonghua Wei Zhong Bing Ji Jiu Yi Xue · 2025-01-01
一句话结论脓毒症患者肌肉活检显示肌纤维横截面积减小、线粒体损伤及171个差异表达蛋白,线粒体功能障碍所致代谢紊乱可能是肌肉减少症的关键因素。

该研究对2例脓毒症严重创伤清创患者和2例非脓毒症开放手术患者的肌肉样本进行HE染色、透射电镜观察和蛋白质组测序。脓毒症组光镜下肌萎缩明显,肌纤维横截面积显著减小(2291.77±807.77 μm² vs 4570.29±1687.53 μm²,P<0.05);电镜下线粒体水肿、空泡化,正常线粒体比例显著降低[(16.8±10.0)% vs(94.4±3.2)%,P<0.05]。蛋白质组学鉴定出171个显著差异表达蛋白(122个上调、49个下调),GO和KEGG富集分析提示生物刺激感知、营养代谢、过氧化物酶体和核因子-κB信号通路激活及矿物质吸收活性降低。作者认为线粒体功能障碍诱导的代谢紊乱可能是脓毒症肌肉减少症的关键因素,靶向线粒体功能恢复肌肉代谢稳态是潜在治疗策略。

要点

  • 脓毒症患者肌肉光镜下肌萎缩明显,肌纤维横截面积较非脓毒症对照组显著减小(2291.77±807.77 μm² vs 4570.29±1687.53 μm²,P<0.05)。
  • 脓毒症患者肌肉电镜下线粒体水肿、空泡化,正常线粒体比例显著低于对照组[(16.8±10.0)% vs(94.4±3.2)%,P<0.05]。
  • 蛋白质组测序鉴定出171个显著差异表达蛋白,其中122个上调、49个下调(上调阈值:倍数变化>1.5且P<0.05;下调阈值:倍数变化<-0.67且P<0.05)。
  • KEGG富集提示脓毒症肌肉组织过氧化物酶体和核因子-κB信号通路显著激活、矿物质吸收活性降低。
  • 作者认为线粒体功能障碍诱导的代谢紊乱可能是脓毒症肌肉减少症的关键因素,靶向线粒体功能是潜在治疗策略。

适用人群与场景

  • 脓毒症组:南京鼓楼医院重症医学科收治的2例接受清创治疗的严重创伤合并脓毒症患者。
  • 对照组:南京鼓楼医院骨科接受开放手术的2例非脓毒症患者。
  • 肌肉样本均通过常规活检程序获取。

诊断标准与关键阈值

  • 显著上调蛋白:倍数变化>1.5且P<0.05。
  • 显著下调蛋白:倍数变化<-0.67且P<0.05。

研究设计与关键结果

  • 研究类型为蛋白质组测序研究,样本为2例脓毒症患者和2例非脓毒症对照的肌肉组织。
  • 光镜下脓毒症组肌萎缩明显,肌纤维横截面积显著减小(2291.77±807.77 μm² vs 4570.29±1687.53 μm²,P<0.05)。
  • 电镜下脓毒症组线粒体水肿、空泡化,正常线粒体比例显著降低[(16.8±10.0)% vs(94.4±3.2)%,P<0.05]。
  • 蛋白质组测序鉴定出171个显著差异表达蛋白,其中122个显著上调、49个显著下调。
  • GO分析显示上调蛋白前10位富集条目主要与刺激反应和膜相关过程有关,下调蛋白前10位富集条目主要与催化和代谢过程有关。
  • KEGG通路分析显示差异表达蛋白前10位富集通路主要涉及解毒和免疫相关过程,包括过氧化物酶体、矿物质吸收、核因子-κB信号通路等,提示过氧化物酶体和核因子-κB信号通路显著激活、矿物质吸收活性降低。

证据类型、等级与局限

  • 证据类型:蛋白质组测序研究。
  • 样本量小(脓毒症组2例、对照组2例)。
  • 作者结论认为线粒体功能障碍诱导的代谢紊乱可能是脓毒症肌肉减少症的关键因素,靶向线粒体功能恢复肌肉代谢稳态是潜在治疗策略。

对床旁实践的改变

  • 作者认为线粒体功能障碍诱导的代谢紊乱可能是脓毒症肌肉减少症的关键因素。
  • 作者认为靶向线粒体功能恢复肌肉代谢稳态是脓毒症等严重情况下肌肉减少症的潜在治疗策略。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

OBJECTIVE: To explore the possible mechanisms underlying the occurrence and development of sarcopenia in clinical sepsis patients based on proteomic sequencing, and to identify potential targets for early intervention and treatment of sarcopenia in severe infectious states such as sepsis.

METHODS: Muscle samples were obtained from two severe trauma patients with sepsis who underwent debridement treatment (sepsis group) hospitalized in the department of critical care medicine of Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, and two non-sepsis patients who underwent open surgery (control group) in the department of orthopedics. Both were obtained through routine biopsy procedures. The morphology of muscle tissue was observed under a light microscope using hematoxylin-eosin (HE) staining; mitochondrial status in muscle tissue was observed under transmission electron microscopy. Further proteomic sequencing of muscle tissue was performed to compare and analyze proteins with significantly differentially expressed proteins. A threshold of fold change > 1.5 and P < 0.05 was set for significantly upregulated proteins, and fold change < -0.67 with P < 0.05 for significantly downregulated proteins. Gene ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analyses were conducted on the significantly differentially expressed proteins.

RESULTS: Compared with the control group, the sepsis group showed significant muscle atrophy under light microscopy, with a markedly reduced cross-sectional area of muscle fibers (μm2: 2 291.77±807.77 vs. 4 570.29±1 687.53, P < 0.05). Electron microscopy revealed mitochondrial edema, vacuolization, and a decreased proportion of normal mitochondria [(16.8±10.0)% vs. (94.4±3.2)%, P < 0.05]. Compared with the control group, proteomic sequencing identified 171 significantly differentially expressed proteins in the sepsis group, including 122 significantly upregulated and 49 significantly downregulated proteins. GO analysis indicated that the top 10 enriched terms for upregulated significantly differentially expressed proteins were primarily related to response to stimulus and membrane-associated processes, including integral component of membrane, intrinsic component of membrane, detection of stimulus, detection of biotic stimulus, response to nutrient, endoplasmic reticulum membrane, endoplasmic reticulum subcompartment, detection of external biotic stimulus, nuclear outer membrane- endoplasmic reticulum membrane network and regulation of reactive oxygen species metabolic process. The top 10 enriched terms for downregulated significantly differentially expressed proteins were mainly associated with catalytic and metabolic processes, including 10-formyltetrahydrofolate catabolic process, folic acid-containing compound catabolic process, pteridine-containing compound catabolic process, 10-formyltetrahydrofolate metabolic process, oxidoreductase activity (acting on the CH-NH group of donors, NAD or NADP as receptors), oxidoreductase activity (acting on the CH-NH group of donors), folic acid-containing compound metabolic process, cellular modified amino acid catabolic process, dicarboxylic acid catabolic process and tetrahydrofolate catabolic process. These findings suggest that differentially expressed proteins in sepsis patients are significantly enriched in processes such as perception of biological stimuli and nutrient metabolism. KEGG pathway analysis revealed that the top 10 enriched pathways for differentially expressed proteins were mainly involved in detoxification and immune-related processes, including peroxisome, mineral absorption, nuclear factor-κB signaling pathway, influenza A, inflammatory bowel disease, nucleocytoplasmic transport, toxoplasmosis, herpes simplex virus 1 infection, ferroptosis and Leishmaniasis, indicating significant activation of peroxisomes and the nuclear factor-κB signaling pathway, and reduced mineral absorption activity in sepsis muscle tissue.

CONCLUSIONS: Mitochondrial dysfunction-induced metabolic disorders may be a key factor in sarcopenia during sepsis. Targeting mitochondrial function to restore muscle metabolic homeostasis represents a potential therapeutic strategy for sarcopenia in severe conditions such as sepsis.

来源:Zhonghua Wei Zhong Bing Ji Jiu Yi Xue,查看原文。版权归原作者所有。

参考来源

  1. Jiang A, Liang X, You Y, et al. [Exploring the potential causes of sarcopenia in sepsis patients based on proteome sequencing]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2025. PMID: 41437585. doi:10.3760/cma.j.cn121430-20241202-00980

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。